Chemotherapy with Acute Leukemia As Secondary Diagnosis Without Cc/Mcc in Pennsylvania
MS-DRG 839: Chemotherapy with acute leukemia as secondary diagnosis without cc/mcc
Billed (list price)Actually paid (Medicare + patient)
| Hospital | City | Medicare stays | Billed | Paid | Cash price | Insurers (median) | |
|---|---|---|---|---|---|---|---|
| Jefferson Abington Hospital | Abington | – | – | – | $13,230 | $20,921$14,500–$29,513 · 22 plans | |
| Lehigh Valley Hospital | Allentown | – | – | – | – | $26,737$14,342–$32,699 · 16 plans | |
| Thomas Jefferson University Hospital | Philadelphia | – | – | – | $17,478 | $28,707$16,492–$45,612 · 23 plans | |
| Upmc Presbyterian Shadyside | Pittsburgh | – | – | – | – | $21,378$17,288–$36,189 · 6 plans |
Medicare: CMS, 2024 (hospitals with 11 or more Medicare stays). Cash and insurer prices: hospitals' own price files, where read; insurer figures are commercial plans only, median and 10th–90th percentile across plans.